Please Wait.....
Report
Egypt In-Vitro Diagnostics Market Research Report Information by Product & Service (Reagents & Kits, Instruments, and Software and Services), by Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, and Others), by Application (Infectious Diseases, Immunology, Oncology, Cardiology, Diabetes, HIV/AIDS, and Others), by End User (Hospitals, Laboratories, Point-of-Care Testing, Research and Academic Institutions, and Others) Forecast to 2032
Market Report I 2025-02-20 I 97 Pages I Market Research Future
Egypt In-Vitro Diagnostics Market Research Report Information by Product & Service (Reagents & Kits, Instruments, and Software and Services), by Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, and Others), by Application (Infectious Diseases, Immunology, Oncology, Cardiology, Diabetes, HIV/AIDS, and Others), by End User (Hospitals, Laboratories, Point-of-Care Testing, Research and Academic Institutions, and Others) Forecast to 2032
Market Overview
Egypt the In-Vitro Diagnostics Market is expected to grow at a robust CAGR of 7.49% during the research period. In-vitro Diagnostic (IVD) refers to medical testing and diagnostic procedures that use blood, urine, tissues, or other bodily fluids collected from a patient's body. These tests are performed outside of the patient's body, usually in a laboratory setting, to detect diseases, infections, disorders, or other medical information. IVD plays an important role in offering vital insights into a patient's health status, assisting in the diagnosis, prognosis, and monitoring of numerous diseases and medical conditions.
The increasing occurrences and prevalence of numerous diseases in Egypt, as well as a growing emphasis on early detection and preventative care, are the primary drivers of the Egypt In-Vitro Diagnostics Market. However, advances in IVD technology, such as the development of more precise, quick, and user-friendly diagnostic tools, are projected to impede worldwide market growth. Nonetheless, the construction and expansion of diagnostic laboratories in Egypt and around the world is expected to provide profitable prospects for the industry.
Marketing Segmentation
The Egypt In-vitro Diagnostic market is divided into three segments based on product and service: reagents and kits, instruments, and software and services.
Based on technology, the Egypt In-vitro Diagnostic market is divided into Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, and Other. The immunoassay/immunochemistry category dominated the market in 2023, while clinical chemistry is expected to be the fastest-growing segment during the forecast period (2024-2032).
According on application, the Egypt In-vitro Diagnostic market is divided into Infectious Diseases, Immunology, Oncology, Cardiology, Diabetes, HIV/AIDS, and Others.
The market is divided into five segments based on end users: hospitals, laboratories, point-of-care testing, research and academic institutions, and others.
Major Players
F. Hoffmann-La Roche Ltd., Siemens Healthineers, Abbott, Thermo Fisher Scientific Inc., Sysmex Corporation, Danaher Corporation, Bio-Rad Laboratories, Inc., and DiaSorin S.p.A. are the leading companies in Egypt's in-vitro diagnostic industry.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 13
1 MARKET INTRODUCTION 15
1.1 DEFINITION 15
1.2 SCOPE OF THE STUDY 15
1.3 RESEARCH OBJECTIVE 15
1.4 MARKET STRUCTURE 16
2 RESEARCH METHODOLOGY 17
2.1 OVERVIEW 17
2.2 DATA FLOW 19
2.2.1 DATA MINING PROCESS 19
2.3 PURCHASED DATABASE: 20
2.4 SECONDARY SOURCES: 21
2.4.1 SECONDARY RESEARCH DATA FLOW: 22
2.5 PRIMARY RESEARCH: 23
2.5.1 PRIMARY RESEARCH DATA FLOW: 24
2.6 APPROACHES FOR MARKET SIZE ESTIMATION: 25
2.6.1 REVENUE ANALYSIS APPROACH 25
2.7 DATA FORECASTING 26
2.7.1 DATA FORECASTING TYPE 26
2.8 DATA MODELING 27
2.8.1 MICROECONOMIC FACTOR ANALYSIS: 27
2.8.2 DATA MODELING: 28
2.9 TEAMS AND ANALYST CONTRIBUTION 30
3 MARKET DYNAMICS 32
3.1 INTRODUCTION 32
3.2 DRIVERS 33
3.2.1 INCREASING INCIDENCES AND PREVELANCES OF VARIOUS DISEASES ACROSS EGYPT 33
3.2.2 GROWING FOCUS ON EARLY DIAGNOSIS AND PREVENTIVE CARE 33
3.3 RESTRAINTS 34
3.3.1 CONCERNS REGARDING THE ACCURACY AND PRECISION OF IN-VITRO DIAGNOSTICS (IVD) 34
3.4 OPPORTUNITY 35
3.4.1 EXPANSION OF MANUFACTURING FACILITIES IN EGYPT 35
4 MARKET FACTOR ANALYSIS 37
4.1 PORTER'S FIVE FORCES MODEL 37
4.1.1 THREAT OF NEW ENTRANTS 37
4.1.2 BARGAINING POWER OF SUPPLIERS 38
4.1.3 THREAT OF SUBSTITUTES 38
4.1.4 BARGAINING POWER OF BUYERS 38
4.1.5 INTENSITY OF RIVALRY 38
4.2 IMPACT OF COVID-19 ON THE EGYPT IN-VITRO DIAGNOSTICS MARKET 39
5 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY PRODUCT & SERVICE 41
5.1 OVERVIEW 41
6 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY TECHNOLOGY 43
6.1 OVERVIEW 43
7 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY APPLICATION 46
7.1 OVERVIEW 46
8 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY END USER 49
8.1 OVERVIEW 49
9 COMPETITIVE LANDSCAPE 52
9.1 INTRODUCTION 52
9.2 MARKET SHARE ANALYSIS, 2023 52
9.3 COMPETITOR DASHBOARD 53
9.4 PUBLIC PLAYERS STOCK SUMMARY 54
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 54
10 COMPANY PROFILES 55
10.1 F. HOFFMANN-LA ROCHE LTD. 55
10.1.1 COMPANY OVERVIEW 55
10.1.2 FINANCIAL OVERVIEW 56
10.1.3 PRODUCTS OFFERED 56
10.1.4 KEY DEVELOPMENTS 58
10.1.5 SWOT ANALYSIS 59
10.1.6 KEY STRATEGIES 59
10.2 ABBOTT 60
10.2.1 COMPANY OVERVIEW 60
10.2.2 FINANCIAL OVERVIEW 61
10.2.3 PRODUCTS OFFERED 61
10.2.4 KEY DEVELOPMENTS 62
10.2.5 SWOT ANALYSIS 63
10.2.6 KEY STRATEGIES 63
10.3 SIEMENS HEALTHINEERS 64
10.3.1 COMPANY OVERVIEW 64
10.3.2 FINANCIAL OVERVIEW 65
10.3.3 PRODUCTS OFFERED 66
10.3.4 KEY DEVELOPMENTS 67
10.3.5 SWOT ANALYSIS 67
10.3.6 KEY STRATEGIES 68
10.4 THERMO FISHER SCIENTIFIC INC. 69
10.4.1 COMPANY OVERVIEW 69
10.4.2 FINANCIAL OVERVIEW 70
10.4.3 PRODUCTS OFFERED 70
10.4.4 KEY DEVELOPMENTS 71
10.4.5 SWOT ANALYSIS 72
10.4.6 KEY STRATEGIES 72
10.5 SYSMEX CORPORATION 73
10.5.1 COMPANY OVERVIEW 73
10.5.2 FINANCIAL OVERVIEW 73
10.5.3 PRODUCTS OFFERED 74
10.5.4 KEY DEVELOPMENTS 76
10.5.5 KEY STRATEGIES 76
10.6 SPECTRUM DIAGNOSTICS 77
10.6.1 COMPANY OVERVIEW 77
10.6.2 FINANCIAL OVERVIEW 77
10.6.3 PRODUCTS OFFERED 77
10.6.4 KEY DEVELOPMENTS 79
10.6.5 KEY STRATEGIES 79
10.7 DANAHER CORPORATION 81
10.7.1 COMPANY OVERVIEW 81
10.7.2 FINANCIAL OVERVIEW 82
10.7.3 PRODUCTS OFFERED 82
10.7.4 KEY DEVELOPMENTS 83
10.7.5 KEY STRATEGIES 83
10.8 DIASORIN S.P.A. 84
10.8.1 COMPANY OVERVIEW 84
10.8.2 FINANCIAL OVERVIEW 85
10.8.3 PRODUCTS OFFERED 86
10.8.4 KEY DEVELOPMENTS 86
10.8.5 KEY STRATEGIES 87
10.9 BIO-RAD LABORATORIES, INC. 88
10.9.1 COMPANY OVERVIEW 88
10.9.2 FINANCIAL OVERVIEW 89
10.9.3 PRODUCTS OFFERED 89
10.9.4 KEY DEVELOPMENTS 91
10.9.5 SWOT ANALYSIS 92
10.9.6 KEY STRATEGIES 92
10.10 RANDOX LABORATORIES LTD. 93
10.10.1 COMPANY OVERVIEW 93
10.10.2 FINANCIAL OVERVIEW 93
10.10.3 PRODUCTS OFFERED 94
10.10.4 KEY DEVELOPMENTS 94
10.10.5 KEY STRATEGIES 95
11 DATA CITATIONS 96
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 28
TABLE 2 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD MILLION) 42
TABLE 3 EGYPT IN-VITRO DIAGNOSTIC MARKET, FOR INSTRUMENTS, BY TYPE, 2019-2032 (USD MILLION) 42
TABLE 4 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 44
TABLE 5 EGYPT IN-VITRO DIAGNOSTIC MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY TYPE 2019-2032 (USD MILLION) 44
TABLE 6 EGYPT IN-VITRO DIAGNOSTIC MARKET, FOR MOLECULAR DIAGNOSTIC, BY TYPE 2019-2032 (USD MILLION) 45
TABLE 7 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 47
TABLE 8 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY END USER, 2019-2032 (USD MILLION) 50
TABLE 9 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 56
TABLE 10 ABBOTT: PRODUCTS OFFERED 61
TABLE 11 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 66
TABLE 12 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 70
TABLE 13 SYSMEX CORPORATION: PRODUCTS OFFERED 74
TABLE 14 SPECTRUM DIAGNOSTICS: PRODUCTS OFFERED 77
TABLE 15 DANAHER CORPORATION: PRODUCTS OFFERED 82
TABLE 16 DIASORIN S.P.A.: PRODUCTS OFFERED 86
TABLE 17 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 89
TABLE 18 RANDOX LABORATORIES LTD.: PRODUCTS OFFERED 94
LIST OF FIGURES
FIGURE 1 EGYPT IN-VITRO DIAGNOSTICS MARKET: STRUCTURE 16
FIGURE 2 EGYPT IN-VITRO DIAGNOSTICS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) 32
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 34
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) 35
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: EGYPT IN-VITRO DIAGNOSTICS MARKET 37
FIGURE 6 EGYPT IN-VITRO DIAGNOSTIC MARKET; PRODUCT & SERVICE SEGMENT ATTRACTIVENESS, (USD MILLION) 41
FIGURE 7 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2023 & 2032 (USD MILLION) 41
FIGURE 8 EGYPT IN-VITRO DIAGNOSTIC MARKET SHARE (%), BY PRODUCT & SERVICE, 2023 42
FIGURE 9 EGYPT IN-VITRO DIAGNOSTIC MARKET: TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD MILLION) 43
FIGURE 10 EGYPT: IN-VITRO DIAGNOSTIC MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION) 43
FIGURE 11 EGYPT IN-VITRO DIAGNOSTIC MARKET SHARE (%), BY TECHNOLOGY, 2023 45
FIGURE 12 EGYPT IN-VITRO DIAGNOSTIC MARKET: APPLICATION SEGMENT ATTRACTIVENESS, (USD MILLION) 46
FIGURE 13 EGYPT IN-VITRO DIAGNOSTIC MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION) 47
FIGURE 14 EGYPT IN-VITRO DIAGNOSTIC MARKET SHARE (%), BY APPLICATION, 2023 48
FIGURE 15 EGYPT IN-VITRO DIAGNOSTIC MARKET: END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 49
FIGURE 16 EGYPT: IN-VITRO DIAGNOSTIC MARKET, BY END USER 2023 & 2032 (USD MILLION) 49
FIGURE 17 EGYPT IN-VITRO DIAGNOSTIC MARKET SHARE (%), BY END USER, 2023 50
FIGURE 18 EGYPT IN-VITRO DIAGNOSTICS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 52
FIGURE 19 COMPETITOR DASHBOARD: EGYPT IN-VITRO DIAGNOSTICS MARKET 53
FIGURE 20 F. HOFFMANN-LA ROCHE LTD.: 56
FIGURE 21 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 59
FIGURE 22 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 61
FIGURE 23 ABBOTT: SWOT ANALYSIS 63
FIGURE 24 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT 65
FIGURE 25 SIEMENS HEALTHINEERS: SWOT ANALYSIS 67
FIGURE 26 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 70
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 72
FIGURE 28 SYSMEX CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 73
FIGURE 29 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 82
FIGURE 30 DIASORIN S.P.A.: FINANCIAL OVERVIEW SNAPSHOT 85
FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 89
FIGURE 32 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 92
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security